Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension

Free Subscription Articles published in J Heart Lung Transplant Retrieve available abstracts of 98 articles: HTML format

Single Articles

October 2025
1. DARIE AM, Doi A, Levvey BJ, Shingles H, et al
   Lung transplantation for chronic thromboembolic pulmonary hypertension - a case series.
   J Heart Lung Transplant. 2025 Oct 7:S1053-2498(25)02305.
   PubMed     Abstract available
   
   
   
2. STEWART DJ, Mehta S, Chandy G, Hirani N, et al
   Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial.
   J Heart Lung Transplant. 2025;44:1663-1667.
   PubMed     Abstract available
   
   
   September 2025
3. ASGHAR U, Man HJ, McInnis M, Ladak AM, et al
   Endothelin-1 Overexpression in Pulmonary Endarterectomy Specimens of CTEPH patients is associated with Pulmonary Hypertension Development.
   J Heart Lung Transplant. 2025 Sep 25:S1053-2498(25)02274.
   PubMed     Abstract available
   
   
   August 2025
4. ANDARELLI JN, Issard J, Lacoste-Palasset T, Mallak I, et al
   Combined Multimodal Therapy in High-Risk Patients with Chronic Thromboembolic Pulmonary Hypertension and Both Distal and Proximal Lesions: A Prospective Observational Cohort Study.
   J Heart Lung Transplant. 2025 Aug 20:S1053-2498(25)02211.
   PubMed     Abstract available
   
   
   
5. NAGARAJ S, Suhotliv A, Yakkali S, Steinberg K, et al
   Hemodynamic Effects of Sotatercept Administration in Pulmonary Hypertension- Insights from Remote Monitoring.
   J Heart Lung Transplant. 2025 Aug 4:S1053-2498(25)02174.
   PubMed     Abstract available
   
   
   
6. MOHAMA D, Worapongsatitaya P, Celestin B, Kazmirczak F, et al
   Comparison of the prognostic value of right atrial echocardiographic parameters in pulmonary arterial hypertension.
   J Heart Lung Transplant. 2025;44:1343-1347.
   PubMed     Abstract available
   
   
   July 2025
7. ALVES-JR JL, Costa ELV, Hoette S, Fernandes CJCDS, et al
   Right ventricular-pulmonary arterial coupling in schistosomiasis associated pulmonary arterial hypertension.
   J Heart Lung Transplant. 2025;44:1024-1032.
   PubMed     Abstract available
   
   
   
8. PYA Y, Bekbossynova M, Medressova A, Latremouille C, et al
   Precise monitoring of transpulmonic resistance in bridge-to-transplant patients supported by the Aeson total artificial heart.
   J Heart Lung Transplant. 2025;44:1161-1164.
   PubMed     Abstract available
   
   
   
9. WIEDENROTH CB, Jenkins D, Brenot P, Lang IM, et al
   Management of chronic thromboembolic pulmonary hypertension.
   J Heart Lung Transplant. 2025;44.
   PubMed     Abstract available
   
   
   
10. JAIS X, Tapson V, Fernandes TM, Fadel E, et al
    Diagnosis of chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2025;44.
    PubMed     Abstract available
    
    
    June 2025
11. FUKUSHI K, Goda A, Kohno T, Takeuchi S, et al
    Revised Definition of Pulmonary Hypertension Subtypes Enhances Prognostic Stratification in Hospitalized Heart Failure Patients.
    J Heart Lung Transplant. 2025 Jun 26:S1053-2498(25)02037.
    PubMed     Abstract available
    
    
    
12. KOLAITIS NA, Singer JP, Bartolome S, Chakinala MM, et al
    The landscape of referrals for lung transplantation in pulmonary arterial hypertension: a report from the Pulmonary Hypertension Association Registry.
    J Heart Lung Transplant. 2025 Jun 26:S1053-2498(25)02055.
    PubMed     Abstract available
    
    
    May 2025
13. NAKATA C, Goda A, Takeuchi K, Takeuchi S, et al
    Prevalence of Occult HFpEF and Age-Specific Efficacy of Passive Leg Raise in Pulmonary Hypertension.
    J Heart Lung Transplant. 2025 May 28:S1053-2498(25)01954.
    PubMed     Abstract available
    
    
    April 2025
14. REDDY SA, Pepke-Zaba J
    Evaluating the Influence of Atrial Fibrillation in Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2025 Apr 11:S1053-2498(25)01909.
    PubMed    
    
    
    
15. SCHNEIDER H, Ius F, Muller C, Salman J, et al
    Paediatric Lung Transplantation for Childhood Interstitial Lung Disease: Indications and Outcome.
    J Heart Lung Transplant. 2025 Apr 8:S1053-2498(25)01899.
    PubMed     Abstract available
    
    
    
16. WELLER S, Li S, Masha L
    Increases in donor/recipient predicted heart mass ratios do not result in large donor right ventricles.
    J Heart Lung Transplant. 2025;44:690-692.
    PubMed     Abstract available
    
    
    
17. GOMBERG-MAITLAND M, Badesch DB, Gibbs JSR, Grunig E, et al
    Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR.
    J Heart Lung Transplant. 2025;44:609-624.
    PubMed     Abstract available
    
    
    
18. BRAKSATOR M, Kurzyna M, Kopec G, Pruszczyk P, et al
    Hemodynamic, echocardiographic, and demographic profiles of patients with chronic thromboembolic pulmonary hypertension and atrial fibrillation: A multicenter cohort study.
    J Heart Lung Transplant. 2025 Apr 1:S1053-2498(25)01858.
    PubMed     Abstract available
    
    
    February 2025
19. ROSENKRANZ S, Ghofrani HA, Hoeper MM, Langleben D, et al
    Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials.
    J Heart Lung Transplant. 2025;44:135-146.
    PubMed     Abstract available
    
    
    January 2025
20. CASCINO TM, Sahay S, Moles VM, McLaughlin VV, et al
    A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension.
    J Heart Lung Transplant. 2025;44:1-10.
    PubMed     Abstract available
    
    
    December 2024
21. NATHAN SD, Kim HC, Chandel A
    Response to: Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.
    J Heart Lung Transplant. 2024;43:2045.
    PubMed    
    
    
    
22. ZISMAN DA
    Comment on: Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.
    J Heart Lung Transplant. 2024;43:2044.
    PubMed    
    
    
    
23. BENZA RL, Chin KM, Gaine S, Galie N, et al
    Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study.
    J Heart Lung Transplant. 2024;43:1998-2007.
    PubMed     Abstract available
    
    
    November 2024
24. GERGES C, Lang IM
    Chronic Thromboembolic Pulmonary Hypertension and Cancer: a true relationship, but one likely beyond coagulation.
    J Heart Lung Transplant. 2024 Nov 23:S1053-2498(24)01968.
    PubMed    
    
    
    October 2024
25. NAKAMURA J, Tsujino I, Masaki K, Hosokawa K, et al
    Cancer as an Independent Mortality Risk in Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2024 Oct 30:S1053-2498(24)01910.
    PubMed     Abstract available
    
    
    
26. BRITO DA ROCHA BR, Yogeswaran A, Lakatos BK, Fabian A, et al
    Loss of Right Ventricular Outflow Function in Pulmonary Hypertension.
    J Heart Lung Transplant. 2024 Oct 9:S1053-2498(24)01881.
    PubMed     Abstract available
    
    
    
27. SIMPSON CE
    The evolving epidemiology of systemic sclerosis-associated pulmonary hypertension.
    J Heart Lung Transplant. 2024;43:1640-1641.
    PubMed    
    
    
    
28. SMITH H, Thompson AAR, Akil M, Alabed S, et al
    The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry.
    J Heart Lung Transplant. 2024;43:1629-1639.
    PubMed     Abstract available
    
    
    
29. GHIO S, Badagliacca R, D'Alto M, Scelsi L, et al
    Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2024;43:1668-1676.
    PubMed     Abstract available
    
    
    
30. BENZA RL, Simonneau G, Ghofrani HA, Corris PA, et al
    Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study.
    J Heart Lung Transplant. 2024;43:1756-1760.
    PubMed     Abstract available
    
    
    September 2024
31. CHIU S, Bunclark K, Appenzeller P, Ghani H, et al
    Impact of Preoperative Body Mass Index on Long-term Survival, Quality of Life, and Functional Outcomes after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Results from the UK National Cohort.
    J Heart Lung Transplant. 2024 Sep 10:S1053-2498(24)01835.
    PubMed     Abstract available
    
    
    
32. GIALAMAS I, Arvanitaki A, Rosenkranz S, Wort SJ, et al
    The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    J Heart Lung Transplant. 2024;43:1383-1394.
    PubMed     Abstract available
    
    
    July 2024
33. GUREVICH S, Prins K
    Balloon Pulmonary Angioplasty: New Quite the Fountain of Youth in Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2024 Jul 5:S1053-2498(24)01729.
    PubMed    
    
    
    May 2024
34. KANEZAWA M, Shimokawahara H, Ejiri K, Goten C, et al
    Effects of medical therapy and age on cardiac output changes following balloon pulmonary angioplasty: Implications for combination therapy in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2024 May 15:S1053-2498(24)01661.
    PubMed     Abstract available
    
    
    April 2024
35. WATABE K, Goda A, Tobita K, Yokoyama S, et al
    Determinants of physical quality of life in patients with chronic thromboembolic pulmonary hypertension after treatment: Insights from invasive exercise stress test.
    J Heart Lung Transplant. 2024 Apr 16:S1053-2498(24)01562.
    PubMed     Abstract available
    
    
    
36. BUNCLARK K, Toshner M
    Anthropometrics are important to consider in purported sex differences in CTEPH outcomes.
    J Heart Lung Transplant. 2024;43:688.
    PubMed    
    
    
    March 2024
37. BARBERA JA, Peinado VI, Blanco I
    UNTANGLING SEVERE PULMONARY HYPERTENSION IN COPD.
    J Heart Lung Transplant. 2024 Mar 22:S1053-2498(24)01538.
    PubMed    
    
    
    February 2024
38. ZEDER K, Marsh LM, Avian A, Brcic L, et al
    Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
    J Heart Lung Transplant. 2024 Feb 19:S1053-2498(24)01087.
    PubMed     Abstract available
    
    
    
39. RAKO ZA, Yogeswaran A, Yildiz S, Weidemann P, et al
    Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension.
    J Heart Lung Transplant. 2024 Feb 17:S1053-2498(24)00056.
    PubMed     Abstract available
    
    
    
40. DESJARDIN JT, Kime N, Kolaitis NA, Kronmal RA, et al
    Investigating the "sex paradox" in pulmonary arterial hypertension: results from the Pulmonary Hypertension Association Registry (PHAR).
    J Heart Lung Transplant. 2024 Feb 13:S1053-2498(24)00044.
    PubMed     Abstract available
    
    
    
41. MCLAUGHLIN V, Farber HW, Highland KB, Hemnes AR, et al
    Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry).
    J Heart Lung Transplant. 2024;43:272-283.
    PubMed     Abstract available
    
    
    
42. CHIA AXF, Valchanov K, Ng C, Tsui S, et al
    Perioperative extracorporeal membrane oxygenation support for pulmonary endarterectomy: A 17-year experience from the UK national cohort.
    J Heart Lung Transplant. 2024;43:241-250.
    PubMed     Abstract available
    
    
    January 2024
43. GHIO S, Corsico A, Rapagnani A, Borrelli E, et al
    Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?
    J Heart Lung Transplant. 2024 Jan 4:S1053-2498(23)02203.
    PubMed     Abstract available
    
    
    
44. JUTANT EM, Chelgham MK, Ottaviani M, Thuillet R, et al
    Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2024;43:120-133.
    PubMed     Abstract available
    
    
    December 2023
45. PARIKH R, Farber HW
    Response to "Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD" by Nathan et al.
    J Heart Lung Transplant. 2023 Dec 27:S1053-2498(23)02199.
    PubMed    
    
    
    
46. JANOWSKI AM, Ravellette KS, Insel M, Garcia JG, et al
    Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02178.
    PubMed     Abstract available
    
    
    
47. CRUZ-UTRILLA A, Lopez-Gude MJ, Velazquez M, Ynsaurriaga FA, et al
    Comment on the article titled "Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension" published by J. Chan et al.
    J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02177.
    PubMed    
    
    
    
48. TAKANO R, Aoki T, Asano R, Ueda J, et al
    Recurrent Pulmonary Hypertension After Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Dec 19:S1053-2498(23)02174.
    PubMed     Abstract available
    
    
    November 2023
49. KIANZAD A, Baccelli A, Braams NJ, Andersen S, et al
    Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function and exercise capacity in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2023 Nov 22:S1053-2498(23)02130.
    PubMed     Abstract available
    
    
    
50. NATHAN SD, Chandel A, Wang Y, Xu J, et al
    Derivation and validation of a non-invasive prediction tool to identify pulmonary hypertension in patients with IPF: evolution of the model FORD.
    J Heart Lung Transplant. 2023 Nov 16:S1053-2498(23)02123.
    PubMed     Abstract available
    
    
    October 2023
51. UKITA R, Patel YJ, Kelly Wu W, Francois SA, et al
    Ambulatory Seven-Day Mechanical Circulatory Support in Sheep Model of Pulmonary Hypertension and Right Heart Failure.
    J Heart Lung Transplant. 2023 Oct 29:S1053-2498(23)02081.
    PubMed     Abstract available
    
    
    August 2023
52. YE JR, Hu SY, Lin YH, Huang CH, et al
    Surgery for fibrosing mediastinitis with severe pulmonary hypertension due to pulmonary venous stenosis.
    J Heart Lung Transplant. 2023 Aug 25:S1053-2498(23)02002.
    PubMed     Abstract available
    
    
    
53. PIENN M, Gertz RJ, Gerhardt F, Kroger JR, et al
    CT-derived Lung Vessel Morphology Correlates with Prognostic Markers in Pre-capillary Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 Aug 22:S1053-2498(23)01973.
    PubMed     Abstract available
    
    
    
54. FERNANDES TM, Kim NH, Kerr KM, Auger WR, et al
    Distal vessel pulmonary thromboendarterectomy: Results from a single institution.
    J Heart Lung Transplant. 2023;42:1112-1119.
    PubMed     Abstract available
    
    
    
55. STOLFO D, Barbisan D, Ameri P, Lombardi CM, et al
    Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
    J Heart Lung Transplant. 2023;42:1082-1092.
    PubMed     Abstract available
    
    
    
56. ZHANG J, Kan J, Wei Y, Zhang C, et al
    Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
    J Heart Lung Transplant. 2023;42:1140-1151.
    PubMed     Abstract available
    
    
    July 2023
57. RAKO ZA, Yogeswaran A, Lakatos BK, Fabian A, et al
    Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension.
    J Heart Lung Transplant. 2023 Jul 12:S1053-2498(23)01935.
    PubMed     Abstract available
    
    
    
58. CHAN JCY, Man HSJ, Asghar UM, McRae K, et al
    Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2023 Jul 6:S1053-2498(23)01897.
    PubMed     Abstract available
    
    
    
59. XIE F, Quan R, Zhang G, Tian H, et al
    Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
    J Heart Lung Transplant. 2023;42:974-984.
    PubMed     Abstract available
    
    
    June 2023
60. WIEDENROTH CB, Guth S
    Response to Huang et al. regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension".
    J Heart Lung Transplant. 2023 Jun 20:S1053-2498(23)01908.
    PubMed    
    
    
    May 2023
61. ASHWIN REDDY S, Swietlik EM, Robertson L, Michael A, et al
    Natural History of Chronic Thromboembolic Pulmonary Disease with no or mild Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 May 16:S1053-2498(23)01848.
    PubMed     Abstract available
    
    
    April 2023
62. STRUEBER M
    TREATMENT STRATEGIES FOR END-STAGE PULMONARY HYPERTENSION.
    J Heart Lung Transplant. 2023 Apr 4:S1053-2498(23)01814.
    PubMed    
    
    
    March 2023
63. HUANG Y, Zhang QZ, Lv SJ
    Comments and opinions regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension".
    J Heart Lung Transplant. 2023 Mar 20:S1053-2498(23)01788.
    PubMed    
    
    
    
64. HADINNAPOLA CM, Southwood M, Hernandez-Sanchez J, Bunclark K, et al
    Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker study.
    J Heart Lung Transplant. 2023;42:398-405.
    PubMed     Abstract available
    
    
    
65. FROST AE, Zhao C, Farber HW, Benza R, et al
    Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes.
    J Heart Lung Transplant. 2023;42:377-389.
    PubMed     Abstract available
    
    
    January 2023
66. NISHIHARA T, Shimokawahara H, Ogawa A, Naito T, et al
    Comparison of the safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with surgically accessible and inaccessible lesions.
    J Heart Lung Transplant. 2023 Jan 19:S1053-2498(23)00007.
    PubMed     Abstract available
    
    
    
67. ROSENKRANZ S, Pausch C, Coghlan JG, Huscher D, et al
    Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
    J Heart Lung Transplant. 2023;42:102-114.
    PubMed     Abstract available
    
    
    
68. URIEL MH, Clerkin KJ, Takeda K, Naka Y, et al
    Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
    J Heart Lung Transplant. 2023;42:124-133.
    PubMed     Abstract available
    
    
    December 2022
69. GALLARDO-VARA E, Ntokou A, Dave JM, Jovin DG, et al
    Vascular pathobiology of pulmonary hypertension.
    J Heart Lung Transplant. 2022 Dec 21:S1053-2498(22)02256.
    PubMed     Abstract available
    
    
    
70. RICHTER MJ, Fortuni F, Alenezi F, D'Alto M, et al
    Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis.
    J Heart Lung Transplant. 2022 Dec 9:S1053-2498(22)02243.
    PubMed     Abstract available
    
    
    
71. KRIECHBAUM SD, Birmes J, Wiedenroth CB, Adameit MSD, et al
    Exercise MR-proANP unmasks latent right heart failure in CTEPH.
    J Heart Lung Transplant. 2022;41:1819-1830.
    PubMed     Abstract available
    
    
    
72. FAUVEL C, Raitiere O, Boucly A, De Groote P, et al
    Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.
    J Heart Lung Transplant. 2022;41:1761-1772.
    PubMed     Abstract available
    
    
    
73. ZI-YANG Y, Hezhi L, Nanshan X, Yin Z, et al
    Model for screening adult congenital heart disease surgery eligibility with echocardiography parameters.
    J Heart Lung Transplant. 2022;41:1831-1838.
    PubMed     Abstract available
    
    
    November 2022
74. HIRSCH K, Nolley S, Ralph DD, Zheng Y, et al
    Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;42:173-82.
    PubMed     Abstract available
    
    
    
75. UKITA R, Stokes JW, Wu WK, Patel YJ, et al
    Large animal preclinical investigation into the optimal extracorporeal life support configuration for pulmonary hypertension and right ventricular failure.
    J Heart Lung Transplant. 2022 Nov 6:S1053-2498(22)02205.
    PubMed     Abstract available
    
    
    
76. BENZA RL, Gomberg-Maitland M, Farber HW, Vizza CD, et al
    Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.
    J Heart Lung Transplant. 2022;41:1572-1580.
    PubMed     Abstract available
    
    
    October 2022
77. DAHIYA G, Kyvernitakis A, Elhamdani A, Begg A, et al
    Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
    J Heart Lung Transplant. 2022 Oct 9:S1053-2498(22)02167.
    PubMed     Abstract available
    
    
    
78. WEATHERALD J, Iqbal H, Mielniczuk L, Syed AR, et al
    Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership.
    J Heart Lung Transplant. 2022 Oct 3. pii: S1053-2498(22)02160.
    PubMed     Abstract available
    
    
    September 2022
79. MCGLOTHLIN DP, Granton J, Klepetko W, Beghetti M, et al
    ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.
    J Heart Lung Transplant. 2022;41:1135-1194.
    PubMed     Abstract available
    
    
    August 2022
80. GARRY JD, Kolaitis NA, Kronmal R, Thenappan T, et al
    Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
    J Heart Lung Transplant. 2022 Aug 28. pii: S1053-2498(22)02085.
    PubMed     Abstract available
    
    
    
81. WIEDENROTH CB, Rolf A, Steinhaus K, Adameit MSD, et al
    Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension.
    J Heart Lung Transplant. 2022 Aug 23. pii: S1053-2498(22)02077.
    PubMed     Abstract available
    
    
    
82. KIANZAD A, van Wezenbeek J, Celant LR, Oosterveer FPT, et al
    Idiopathic pulmonary arterial hypertension patients with a high H2FPEF-score: Insights from the Amsterdam UMC PAH-cohort.
    J Heart Lung Transplant. 2022;41:1075-1085.
    PubMed     Abstract available
    
    
    
83. BONTA PI, Tramper J, Eberl S, Tepaske R, et al
    Endobronchial blocker use for massive, focal pulmonary hemorrhage during pulmonary endarterectomy for CTEPH.
    J Heart Lung Transplant. 2022;41:1130-1133.
    PubMed     Abstract available
    
    
    July 2022
84. GULATI G, Grandin EW, DeNofrio D, Upshaw JN, et al
    Association between postoperative hemodynamic metrics of pulmonary hypertension and right ventricular dysfunction and clinical outcomes after left ventricular assist device implantation.
    J Heart Lung Transplant. 2022 Jul 23. pii: S1053-2498(22)02029.
    PubMed     Abstract available
    
    
    
85. HALPERN SE, Wright MC, Madsen G, Chow B, et al
    Textbook outcome in lung transplantation: Planned venoarterial extracorporeal membrane oxygenation versus off-pump support for patients without pulmonary hypertension.
    J Heart Lung Transplant. 2022 Jul 21. pii: S1053-2498(22)02041.
    PubMed     Abstract available
    
    
    
86. REDDY SA, Nethercott SL, Teh W, De Bie EM, et al
    Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:861-865.
    PubMed     Abstract available
    
    
    
87. HOEPER MM, Pausch C, Olsson KM, Huscher D, et al
    Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
    J Heart Lung Transplant. 2022;41:971-981.
    PubMed     Abstract available
    
    
    June 2022
88. VICAIRE H, Pavec JL, Mercier O, Montani D, et al
    Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
    J Heart Lung Transplant. 2022 Jun 6. pii: S1053-2498(22)01974.
    PubMed     Abstract available
    
    
    
89. BADAGLIACCA R, Rischard F, Giudice FL, Howard L, et al
    Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:780-790.
    PubMed     Abstract available
    
    
    
90. ABDELNOUR-BERCHTOLD E, Donahoe L, McRae K, Asghar U, et al
    Central venoarterial extracorporeal membrane oxygenation as a bridge to recovery after pulmonary endarterectomy in patients with decompensated right heart failure.
    J Heart Lung Transplant. 2022;41:773-779.
    PubMed     Abstract available
    
    
    
91. SUN QW, Sun Z
    Stem cell therapy for pulmonary arterial hypertension: An update.
    J Heart Lung Transplant. 2022;41:692-703.
    PubMed     Abstract available
    
    
    May 2022
92. WIEDENROTH CB, Deissner H, Adameit MSD, Kriechbaum SD, et al
    Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: Impact on the outcome.
    J Heart Lung Transplant. 2022 May 20. pii: S1053-2498(22)01944.
    PubMed     Abstract available
    
    
    
93. WEATHERALD J, Thakrar MV, Varughese RA, Kularatne M, et al
    Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.
    J Heart Lung Transplant. 2022;41:563-567.
    PubMed     Abstract available
    
    
    
94. GAIOTTO FA, Bacal F, Steffen SP, Marcondes-Braga FG, et al
    A modified heterotopic heart transplant technique to bridge patients with "fixed" pulmonary hypertension: A case report.
    J Heart Lung Transplant. 2022 May 1. pii: S1053-2498(22)01917.
    PubMed    
    
    
    April 2022
95. VAN WEZENBEEK J, Groeneveldt JA, Llucia-Valldeperas A, van der Bruggen CE, et al
    Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort.
    J Heart Lung Transplant. 2022;41:445-457.
    PubMed     Abstract available
    
    
    March 2022
96. BENZA RL, Boucly A, Farber HW, Frost AE, et al
    Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.
    J Heart Lung Transplant. 2022;41:411-420.
    PubMed     Abstract available
    
    
    February 2022
97. HUMBERT M, Simonneau G, Pittrow D, Delcroix M, et al
    Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2022 Feb 11. pii: S1053-2498(22)01804.
    PubMed     Abstract available
    
    
    October 2021
98. HANSMANN G, Diekmann F, Chouvarine P, Ius F, et al
    Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH.
    J Heart Lung Transplant. 2021 Oct 29. pii: S1053-2498(21)02568.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.